John Glasspool is a global pharmaceutical executive who currently serves as the CEO of VarmX. With extensive experience leading franchises with sales exceeding $6 billion across multiple regions, John has been instrumental in bridging the gap between science and business and has held leadership roles at several biopharmaceutical companies, including Anthos Therapeutics and Baxalta. A holder of two patents in neuroscience and cardiovascular treatment, John is also active on the board of the Biotechnology Innovation Organization and contributes as a senior advisor at the Massachusetts Institute of Technology's NEWDIGS initiative. John has completed postgraduate studies in Clinical Pharmacology, Development, and Regulation, and holds a Bachelor of Arts in Politics and International Relations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices